Simian virus 40 and lymphoproliferative disorder.
Della Porta
Matteo Giovanni
MG
University of Pavia Medical School, Division of Hematology, IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Malcovati
Luca
L
D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000032:analysis*; D016022:Case-Control Studies; D003364:Costa Rica / Q000453:epidemiology; D004340:Drug Contamination; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000821:virology; D008223:Lymphoma / Q000453:epidemiology / Q000821:virology; D016393:Lymphoma, B-Cell / Q000453:epidemiology / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000453:epidemiology / Q000821:virology*; D009374:Neoplasms, Experimental / Q000821:virology; D011054:Poliovirus Vaccine, Inactivated; D027601:Polyomavirus Infections / Q000453:epidemiology* / Q000821:virology; D019310:Pseudolymphoma / Q000453:epidemiology / Q000821:virology; D012377:Rodentia; D013539:Simian virus 40 / Q000302:isolation & purification / Q000472:pathogenicity*; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000821:virology; D014412:Tumor Virus Infections / Q000453:epidemiology* / Q000821:virology
D000952:Antigens, Polyomavirus Transforming; D011054:Poliovirus Vaccine, Inactivated